Canadian cannabis corporation Canopy Development Corp. CGC, +.69% WEED, +.00% stated MOnday it has come to be the exclusive supplier of health-related cannabis to Luxembourg in a deal that extends by way of Dec. 31, 2021. Luxembourg launched a health-related cannabis system by decriminalizing it for sufferers with extreme unmet desires in 2018. The Duchy is also anticipated to totally legalize the production and consumption of recreational cannabis in the close to term and may perhaps be the 1st European nation to do so. Canopy will deliver cannabis to the Duchy by means of its Spectrum Therapeutics subsidiary. Spectrum has also been granted a license to shop and distribute health-related cannabis-primarily based merchandise in the UK. The UK has had a health-related system for much less than a year. “We are actively operating with regulators to come across the greatest way to make certain we can provide continuous remedy to sufferers inside the framework,” Cosmo Feilding Mellen, managing director of Spectrum in the UK stated in a statement. Canopy’s U.S.-listed shares rose 1.9% in premarket trade, but are down 25% in 2019, even though the ETFMG Option Harvest ETF MJ, +1.58% has fallen 21% and the S&P 500 SPX, +.69% has gained 19%.